findmyKOL
Clinical trialNCT06335173Active, not recruitingPhase 2Interventional

A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

SponsorAcumen PharmaceuticalsEnrollment542Alzheimer Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

68 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Okanagan Clinical Trials

    Kelowna, British Columbia, Canada

  • Hippocampe D/b/a Ottawa Memory Clinic

    Ottawa, Ontario, Canada

  • Toronto Memory Program (tmp) (neurology Research Inc.)

    Toronto, Ontario, Canada

  • Moca Research and Innovations

    Greenfield Park, Quebec, Canada

Germany
  • Charité - Universitaetsmedizin Berlin

    Berlin, Germany

  • University Hospital of Cologne

    Cologne, Germany

  • Zentralinstitut Für Seelische Gesundheit

    Mannheim, Germany

  • Technical University of Munich, School of Medicine and Health, Klinikum Rechts Der Isar

    Munich, Germany

Spain
  • Hospital Universitari General de Catalunya

    Sant Cugat del Vallès, Barcelona, Spain

  • Fundacion Neuropolis - Hospital Viamed Montecanal

    Cuarte de Huerva, Zaragoza, Spain

  • Fundacio Ace

    Barcelona, Spain

  • Policlínica Gipuzkoa

    Donostia / San Sebastian, Spain

  • Cae Oroitu

    Getxo, Spain

  • Hospital Ruber

    Madrid, Spain

  • Hospital Victoria Eugenia

    Seville, Spain

  • Hospital Universitari I Politècnic la Fe

    Valencia, Spain

United Kingdom
  • Re:cognition Health - London

    London, Greater London, United Kingdom

  • St. Pancras Clinical Research Ltd.

    London, Greater London, United Kingdom

  • Re:cognition Health - Winchester

    Winchester, Hampshire, United Kingdom

  • Neuroclin Glasgow

    Motherwell, Lanarkshire, United Kingdom

  • Panthera Bio-Partners - Preston

    Preston, Lancashire, United Kingdom

  • Re:cognition Health - Guildford

    Guildford, Surrey, United Kingdom

  • Panthera Biopartners - Sheffield

    Sheffield, Yorkshire, United Kingdom

  • Re:cognition Health - Bristol

    Bristol, United Kingdom

United States
  • the Neurology Center of Southern California - Carlsbad

    Carlsbad, California, United States

  • Neurology Center of North Orange County

    Fullerton, California, United States

  • Irvine Medical Research

    Irvine, California, United States

  • Healthy Brain Research

    Long Beach, California, United States

  • Syrentis Clinical Research

    Santa Ana, California, United States

  • Cenexel - California Neuroscience Research Medical Group, Inc (cnr)

    Sherman Oaks, California, United States

  • Research Center for Clinical Studies, Llc

    Norwalk, Connecticut, United States

  • Re:cognition Health - Fairfax

    Washington D.C., District of Columbia, United States

  • Jem Research Institute

    Atlantis, Florida, United States

  • Bradenton Research Center

    Bradenton, Florida, United States

  • Gil Fernandez-Yera, Md, Pa

    Coral Gables, Florida, United States

  • Brain Matters Research

    Delray Beach, Florida, United States

  • Coral Clinical Research

    Homestead, Florida, United States

  • K2 Medical Research - Villages

    Lady Lake, Florida, United States

  • Finlay Medical Research

    Miami, Florida, United States

  • Aqualane Clinical Research

    Naples, Florida, United States

28 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2024
Primary completion
31 Oct 2026
Completion
31 Oct 2026
Last update posted
27 Oct 2025
Registered enrollment
542
Registry id
NCT06335173

Cross-registrations

EU-CTR / CTIS (EudraCT)2023-509807-34-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.